We believe a comprehensive, data and technology driven approach to care will significantly increase the odds of permanent addiction recovery.
Together with esteemed partners, and through rigorous clinical study, we are developing a unique treatment system and highly specialized tools to personalize care, from assessment to treatment and beyond.
What is DMT?
Well tolerated with few adverse effects, pure DMT is the ideal molecule for advancing and sustaining new models of psychedelic-assisted therapy. DMT has a robust and well demonstrated capacity to affect neuronal activity and promote brain plasticity when administered in the optimum set and setting, providing valuable insights, a healthier reorientation to the past, and the ability to remedy the underlying neurological and emotional mechanisms of addiction.
Utilizing the powerful DMT molecule. Entheon will lead patients through an assisted therapeutic experience, allowing patients to erase problematic neural pathways fueling addiction and mental illness, and facilitate the creation of new pathways towards recovery.
The Entheon Intelligence Platform
A Patient-Centric and Personalized System of Psychedelic Medicine
With a core-concentration on advancing DMT’s therapeutic potential, Entheon is developing a combination of genetic and predictive data analysis to ensure the safest psychedelic treatment possible.
Entheon’s genetic testing subsidiary, HaluGen Life Sciences, conducts diligent genetic testing to determine the risk probability of different psychedelic molecules for a given patient before the treatment takes place.
Using patient and clinical trial data, Entheon is developing a predictive biomarker response platform in partnership with Divergence Neuro Tech. Using Divergence’s proprietary neuro platform in tandem with electroencephalographic monitoring (EEG),
Entheon’s biomarker platform, powered by AI and machine learning, will better prescribe suitable psychedelic treatments, provide real-time feedback during a psychedelic event, and inform the development of a post-therapy system of patient-specific support.